Browsing Tag
Pharmaceutical Innovation
12 posts
XtalPi and Pfizer deepen AI-powered drug discovery alliance with enhanced molecular modeling platform for small molecule breakthroughs
XtalPi expands collaboration with Pfizer to build high-throughput AI-driven molecular modeling platform for small molecule discovery. Read the full strategic update.
Suven Pharmaceuticals acquires majority stake in NJ Bio, strengthens US presence
Suven Pharmaceuticals Limited, a technology-focused contract development and manufacturing organisation (CDMO), has announced the acquisition of a controlling…
Everest Medicines’ EVER001 shows promising Phase 1b/2a trial results for autoimmune kidney disease treatment
Everest Medicines has announced promising preliminary results from its ongoing Phase 1b/2a clinical trial of EVER001, a next-generation…
Could this startup have the cure for obesity? Meet Pep2Tango Therapeutics!
Versant Ventures has introduced Pep2Tango Therapeutics Inc., a biotechnology startup dedicated to pioneering next-generation therapies for weight loss.…
Lupin Limited appoints Abdelaziz Toumi as CEO of new subsidiary
Global pharmaceutical giant, Lupin Limited, announced the appointment of Abdelaziz Toumi (commonly known as Abdel) as the Chief…
Strides Pharma Science gets FDA approval for Fluoxetine Tablets for depressive disorders
Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by…
Gland Pharma receives USFDA approval for first generic Eribulin Mesylate Injection
In a significant advancement for generic pharmaceuticals, Gland Pharma Limited, a company specializing in generic injectable-focused pharmaceutical products,…
Zydus Lifesciences announces WHO approval for NLRP3 inhibitor Usnoflast
Zydus Lifesciences, a discovery-based, global pharmaceutical leader, has recently received approval from the World Health Organization (WHO) International…
Zydus Lifesciences receives tentative FDA approval for Letermovir tablets
In a significant development for patients undergoing bone marrow or kidney transplants, Zydus Lifesciences Limited has been granted…
Gilead Sciences completes $4.3bn acquisition of CymaBay Therapeutics to enhance liver disease portfolio
Gilead Sciences, Inc. (Nasdaq: GILD) has officially announced the successful acquisition of CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for…